November PMI index drops to 53.1%

The export demand component of the index fell 7.8 points in November.

By SHARON WROBEL
December 17, 2007 08:20

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Industrial activity slipped again in November as the Purchasing Mangers' Index dropped 3.2 percentage points to 53.1%, after falling 7.4 points in October, research company Dun & Bradstreet Israel reported Sunday. The domestic demand component of the PMI fell by 3.7 percentage points in November to 48.2%, its first decline in 15 months, sliding below the economic expansion threshold. PMI values above 50% reflect growth, and D&B economists said they were concerned about a possible slowdown in the economy should the decline of the domestic demand component continue over the next few months. The export demand component of the index fell 7.8 points in November.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS